Back
ESC Premium Access

Role of clopidogrel loading dose in patients undergoing transcatheter aortic valve implantation: results from the BRAVO-3 randomized trial

Session: Current data on TAVI outcomes
Topic: Non coronary cardiac interventions
Speaker: Doctor V. Nijenhuis (Nieuwegein, NL)
Event: ESC Congress 2016

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vincent Johan Nijenhuis

St Antonius Hospital, Nieuwegein (Netherlands (The))
0 follower

6 more presentations in this session

Transcatheter aortic valve implantation: efficacy, safety and mortality at 30-days to 1-year from a nationwide eight year registry

Speaker: Doctor P. Canas da Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry

Speaker: Doctor P. Canas da Silva (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Impact of residual coronary artery disease on patients undergoing TAVI: a multicenter study

Speaker: Doctor S. Taha (Assiut, EG)

Access
Abstract
Slides
Like
Thumbnail

Effect of body mass index on mortality after transcatheter aortic valve implantation: J-shaped curve.

Speaker: Ms R. GONZALEZ FERREIRO (Vigo, ES)

Access
Abstract
Like
Thumbnail

Acute kidney injury following transcatheter aortic valve implantation: does it affect long-term outcomes?

Speaker: Doctor A. Bacelar (Sao Paulo, BR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Current data on TAVI outcomes

Speakers: Doctor V. Nijenhuis, Doctor P. Canas da Silva, Doctor P. Canas da Silva, Doctor S. Taha, Ms R. GONZALEZ FERREIRO...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources